Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļTEVA
āļāļ·āđāļāļāļĢāļīāļĐāļąāļTeva Pharmaceutical Industries Ltd
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļFeb 06, 2087
āļāļĩāļāļĩāđāļFrancis (Richard D)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ33892
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒDepository Receipt
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļFeb 06
āļāļĩāđāļāļĒāļđāđ124 Dvora Hanevi'a St.
āđāļĄāļ·āļāļTEL AVIV-YAFO
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX NASDAQ Basic NYSE
āļāļĢāļ°āđāļāļĻIsrael
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ6944020
āđāļāļĢāļĻāļąāļāļāđ97239148213
āđāļ§āđāļāđāļāļāđhttps://www.tevapharm.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļTEVA
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļFeb 06, 2087
āļāļĩāļāļĩāđāļFrancis (Richard D)
Prof. Varda Shalev
Independent Director
Ms. Christine (Chris) Fox
Ms. Christine (Chris) Fox
Executive Vice President - U.S. Commercial
Executive Vice President - U.S. Commercial
Mr. Amir Elstein
Independent Director
Mr. Mark Sabag
Executive Vice President - International Markets Commercial
Executive Vice President - International Markets Commercial
Dr. Sol J. Barer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
Ms. Rosemary A. (Rose) Crane
Ms. Rosemary A. (Rose) Crane
Independent Director
Mr. Gerald M. (Jerry) Lieberman
Mr. Gerald M. (Jerry) Lieberman
Independent Director
Mr. Richard Daniell
Executive Vice President - European Commercial
Executive Vice President - European Commercial
Mr. Roberto A. Mignone
Independent Director
Dr. Perry D. Nisen, M.D., Ph.D.
Dr. Perry D. Nisen, M.D., Ph.D.
Independent Director
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Prof. Varda Shalev
Independent Director
Ms. Christine (Chris) Fox
Ms. Christine (Chris) Fox
Executive Vice President - U.S. Commercial
Executive Vice President - U.S. Commercial
Mr. Amir Elstein
Independent Director
Mr. Mark Sabag
Executive Vice President - International Markets Commercial
Executive Vice President - International Markets Commercial
Dr. Sol J. Barer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
Ms. Rosemary A. (Rose) Crane
Ms. Rosemary A. (Rose) Crane
Independent Director
VanEck Pharmaceutical ETF
First Trust WCM Developing World Equity ETF
First Trust WCM International Equity ETF
ARK Israel Innovative Technology ETF
WealthTrust DBS Long Term Growth ETF
WisdomTree International Multifactor Fund
iShares Health Innovation Active ETF
iShares MSCI Intl Value Factor ETF
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
iShares MSCI Israel ETF
āļŠāļąāļāļŠāđāļ§āļ7.76%
VanEck Israel ETF
āļŠāļąāļāļŠāđāļ§āļ7.5%
VanEck Pharmaceutical ETF
āļŠāļąāļāļŠāđāļ§āļ3.79%
First Trust WCM Developing World Equity ETF
āļŠāļąāļāļŠāđāļ§āļ3.16%
First Trust WCM International Equity ETF
āļŠāļąāļāļŠāđāļ§āļ2.64%
ARK Israel Innovative Technology ETF
āļŠāļąāļāļŠāđāļ§āļ1.81%
WealthTrust DBS Long Term Growth ETF
āļŠāļąāļāļŠāđāļ§āļ1.42%
WisdomTree International Multifactor Fund
āļŠāļąāļāļŠāđāļ§āļ0.77%
iShares Health Innovation Active ETF
āļŠāļąāļāļŠāđāļ§āļ0.69%
iShares MSCI Intl Value Factor ETF
āļŠāļąāļāļŠāđāļ§āļ0.46%
āļĄāļĩāļāļēāļĢāļāđāļēāļĒāđāļāļīāļāļāļąāļāļāļĨāđāļāđāļāļāļģāļāļ§āļāļĢāļ§āļĄ
0.00
USD āđāļāļāđāļ§āļ 5 āļāļĩāļāļĩāđāļāđāļēāļāļĄāļē

āđāļĄāđāļĄāļĩāļāđāļāļĄāļđāļĨ